JP2014525394A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014525394A5 JP2014525394A5 JP2014524449A JP2014524449A JP2014525394A5 JP 2014525394 A5 JP2014525394 A5 JP 2014525394A5 JP 2014524449 A JP2014524449 A JP 2014524449A JP 2014524449 A JP2014524449 A JP 2014524449A JP 2014525394 A5 JP2014525394 A5 JP 2014525394A5
- Authority
- JP
- Japan
- Prior art keywords
- alopecia
- seq
- acid sequence
- amino acid
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 201000004384 Alopecia Diseases 0.000 claims 19
- 125000003275 alpha amino acid group Chemical group 0.000 claims 15
- 231100000360 alopecia Toxicity 0.000 claims 12
- 229920001184 polypeptide Polymers 0.000 claims 10
- 102000004196 processed proteins & peptides Human genes 0.000 claims 10
- 108090000765 processed proteins & peptides Proteins 0.000 claims 10
- 239000012634 fragment Substances 0.000 claims 9
- 230000003676 hair loss Effects 0.000 claims 5
- 208000024963 hair loss Diseases 0.000 claims 4
- 230000002265 prevention Effects 0.000 claims 4
- 102000004264 Osteopontin Human genes 0.000 claims 3
- 108010081689 Osteopontin Proteins 0.000 claims 3
- 150000001413 amino acids Chemical class 0.000 claims 3
- 201000002996 androgenic alopecia Diseases 0.000 claims 3
- 230000003779 hair growth Effects 0.000 claims 3
- 230000003698 anagen phase Effects 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 230000001737 promoting effect Effects 0.000 claims 2
- 230000003797 telogen phase Effects 0.000 claims 2
- 101000993347 Gallus gallus Ciliary neurotrophic factor Proteins 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- 208000004631 alopecia areata Diseases 0.000 claims 1
- 206010068168 androgenetic alopecia Diseases 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 230000001613 neoplastic effect Effects 0.000 claims 1
- 230000001575 pathological effect Effects 0.000 claims 1
- 230000037390 scarring Effects 0.000 claims 1
- 230000009885 systemic effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1113770.0A GB2493540A (en) | 2011-08-10 | 2011-08-10 | Agents for stimulating hair growth in mammals |
| GB1113770.0 | 2011-08-10 | ||
| PCT/GB2012/051955 WO2013021212A2 (en) | 2011-08-10 | 2012-08-10 | Novel compositions and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014525394A JP2014525394A (ja) | 2014-09-29 |
| JP2014525394A5 true JP2014525394A5 (enExample) | 2015-09-17 |
| JP6049718B2 JP6049718B2 (ja) | 2016-12-21 |
Family
ID=44735704
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014524449A Active JP6049718B2 (ja) | 2011-08-10 | 2012-08-10 | 新規組成物及びその使用 |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US9381149B2 (enExample) |
| EP (2) | EP2741761B1 (enExample) |
| JP (1) | JP6049718B2 (enExample) |
| KR (1) | KR101992282B1 (enExample) |
| CN (1) | CN103930125B (enExample) |
| AU (1) | AU2012293448B2 (enExample) |
| BR (1) | BR112014003051B1 (enExample) |
| CA (1) | CA2844749C (enExample) |
| DK (2) | DK2741761T3 (enExample) |
| ES (2) | ES2740826T3 (enExample) |
| GB (1) | GB2493540A (enExample) |
| PL (2) | PL2741761T3 (enExample) |
| RU (1) | RU2604797C2 (enExample) |
| TR (1) | TR201910685T4 (enExample) |
| WO (1) | WO2013021212A2 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2493540A (en) | 2011-08-10 | 2013-02-13 | Follicum Ab | Agents for stimulating hair growth in mammals |
| GB201406989D0 (en) * | 2014-04-17 | 2014-06-04 | Follicum Ab | Novel treatments |
| JP6548126B2 (ja) * | 2014-11-27 | 2019-07-24 | 国立大学法人大阪大学 | Ｉｉｉ型コラーゲン産生促進剤 |
| KR101906557B1 (ko) * | 2015-08-06 | 2018-10-11 | 서울대학교산학협력단 | 합성 펩타이드를 이용한 유도만능줄기세포의 제조방법 |
| EP3600108A4 (en) * | 2017-03-23 | 2021-01-06 | The Regents of the University of California | STIMULATION OF HAIR GROWTH BY SENESCENCE CELLS AND SENESCENCE-ASSOCIATED SECRETORIC PHENOTYPE |
| AU2018262805B2 (en) * | 2017-05-04 | 2022-02-17 | Follicum Ab | Peptides for treatment of diabetes |
| KR102091567B1 (ko) * | 2018-06-15 | 2020-03-20 | 인하대학교 산학협력단 | 오스테오폰틴 단백질 단편을 유효성분으로 함유하는 뇌손상 예방 또는 치료용 약학 조성물 |
| US20220002343A1 (en) * | 2018-11-07 | 2022-01-06 | Follicum Ab | Peptide fragments for treatment of diabetes |
| US20220273765A1 (en) * | 2019-04-24 | 2022-09-01 | Follicum Ab | Topical formulation |
| EP4110461A4 (en) * | 2020-02-25 | 2024-05-01 | Amplifica, Inc. | COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH |
| AU2022335599A1 (en) * | 2021-08-25 | 2024-03-07 | Amplifica Holdings Group, Inc. | Compositions and methods for stimulating hair growth |
| WO2023218095A1 (en) * | 2022-05-13 | 2023-11-16 | Coegin Pharma Ab | Agents for stimulating tissue regeneration |
| CN119300852A (zh) * | 2022-05-13 | 2025-01-10 | 科京制药公司 | 诱导血管形成的药剂 |
| AU2024311323C1 (en) * | 2023-06-20 | 2026-06-11 | Amplifica Holdings Group, Inc. | Compositions and methods for stimulating hair growth |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE459005B (sv) | 1985-07-12 | 1989-05-29 | Aake Rikard Lindahl | Saett att framstaella sfaeriska polymerpartiklar |
| US5643872A (en) | 1989-10-23 | 1997-07-01 | Smithkline Beecham Corporation | Cyclic anti-aggregatory peptides |
| US5756094A (en) | 1991-03-27 | 1998-05-26 | Trustees Of The University Of Pennsylvania | Methods for stimulating follicular growth |
| US5753612A (en) | 1992-10-27 | 1998-05-19 | Yissum Research Development Co. Of The Hebrew University Of Jerusalem | Pharmaceutical composition and method for inhibiting hair growth by administration of activin or activin agonists |
| US6008058A (en) | 1993-06-18 | 1999-12-28 | University Of Louisville | Cyclic peptide mixtures via side chain or backbone attachment and solid phase synthesis |
| EP0821592A4 (en) * | 1995-04-20 | 2000-03-01 | Univ Pennsylvania | COMPOSITIONS AND METHODS FOR REGULATING HAIR GROWTH |
| CA2192782C (en) | 1995-12-15 | 2008-10-14 | Nobuyuki Takechi | Production of microspheres |
| WO2001028509A1 (en) | 1999-10-21 | 2001-04-26 | Kao Corporation | Depilatories and agents for external use |
| EP1269196B1 (en) | 2000-03-23 | 2007-11-21 | Glaxo Group Limited | Method of screening for inhibitors of osteopontin |
| US6428967B1 (en) * | 2000-05-01 | 2002-08-06 | Board Of Regents, The University Of Texas System | LDL receptor signaling pathways |
| AU2002220920A1 (en) * | 2000-12-08 | 2002-06-18 | Oxford Biomedica (Uk) Limited | Method for identification of genes involved in specific diseases |
| PL366469A1 (en) | 2001-04-05 | 2005-02-07 | Immuno-Biological Laboratories Co, Ltd. | Anti-osteopontin antibody and use thereof |
| ES2387082T3 (es) * | 2001-05-17 | 2012-09-13 | Merck Serono Sa | Uso de OSTEOPONTINA para el tratamiento y/o prevención de enfermedades neurológicas |
| CN101665538A (zh) | 2003-12-18 | 2010-03-10 | 诺沃挪第克公司 | 与白蛋白样物质相连的新glp-1类似物 |
| WO2005066339A2 (en) | 2004-01-06 | 2005-07-21 | Novozymes A/S | Polypeptides of alicyclobacillus sp. |
| AR048024A1 (es) * | 2004-03-05 | 2006-03-22 | Bayer Cropscience Gmbh | Plantas con actividad aumentada de distintas enzimas fosforilantes del almidon |
| RU2309730C2 (ru) * | 2006-04-18 | 2007-11-10 | Леонид Юрьевич Брежнев | Средство для стимуляции роста волос, его варианты и способ его получения |
| WO2008086449A2 (en) * | 2007-01-09 | 2008-07-17 | Oregon Health & Science University | Synthetic osteopontin peptides and methods of use |
| GB2493540A (en) | 2011-08-10 | 2013-02-13 | Follicum Ab | Agents for stimulating hair growth in mammals |
-
2011
- 2011-08-10 GB GB1113770.0A patent/GB2493540A/en not_active Withdrawn
-
2012
- 2012-08-10 DK DK12768879.4T patent/DK2741761T3/en active
- 2012-08-10 TR TR2019/10685T patent/TR201910685T4/tr unknown
- 2012-08-10 ES ES16169698T patent/ES2740826T3/es active Active
- 2012-08-10 EP EP12768879.4A patent/EP2741761B1/en active Active
- 2012-08-10 RU RU2014108819/10A patent/RU2604797C2/ru active
- 2012-08-10 ES ES12768879.4T patent/ES2576299T3/es active Active
- 2012-08-10 BR BR112014003051-0A patent/BR112014003051B1/pt active IP Right Grant
- 2012-08-10 US US14/237,108 patent/US9381149B2/en active Active
- 2012-08-10 PL PL12768879T patent/PL2741761T3/pl unknown
- 2012-08-10 CN CN201280049850.XA patent/CN103930125B/zh active Active
- 2012-08-10 AU AU2012293448A patent/AU2012293448B2/en active Active
- 2012-08-10 PL PL16169698T patent/PL3087999T3/pl unknown
- 2012-08-10 CA CA2844749A patent/CA2844749C/en active Active
- 2012-08-10 EP EP16169698.4A patent/EP3087999B1/en active Active
- 2012-08-10 JP JP2014524449A patent/JP6049718B2/ja active Active
- 2012-08-10 WO PCT/GB2012/051955 patent/WO2013021212A2/en not_active Ceased
- 2012-08-10 KR KR1020147006108A patent/KR101992282B1/ko active Active
- 2012-08-10 DK DK16169698.4T patent/DK3087999T3/da active
-
2016
- 2016-06-16 US US15/184,290 patent/US10137169B2/en active Active
-
2018
- 2018-10-31 US US16/176,201 patent/US10517932B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012511545A5 (enExample) | ||
| WO2012084532A3 (de) | Verfahren zur umformung keratinhaltiger fasern | |
| BR112012033117A2 (pt) | pirazolo[1,5-a]pirimidinas como agentes antivirais | |
| SG11201901996UA (en) | Formulations of ( r)-2-amino-3-phenylpropyl carbamate | |
| JP2020521797A5 (enExample) | ||
| WO2006026617A3 (en) | Compositions and methods of promoting hair growth | |
| TN2012000416A1 (en) | Fused tricyclic silyl compounds and methods of use thereof for the treatment of viral diseases | |
| NZ611468A (en) | Humanized antibodies to liv-1 and use of same to treat cancer | |
| WO2012051629A3 (en) | Compositions and methods for treating keratin based fibers | |
| EA202090053A2 (ru) | Способы и композиции для лечения неэффективного эритропоэза | |
| HK1199879A1 (en) | Pde9 inhibitors with imidazo triazinone backbone | |
| WO2010011772A3 (en) | Tri-cyclic pyrazolopyridine kinase inhibitors | |
| NZ611620A (en) | Cyclosporine analogue molecules modified at amino acid 1 and 3 | |
| WO2009022215A8 (en) | Combination motif immune stimulatory oligonucleotides with improved activity | |
| PL1663197T3 (pl) | Zastosowanie pochodnych kwasu fumarowego do leczenia niewydolności serca oraz astmy | |
| WO2012018534A3 (en) | Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases | |
| JP2008513439A5 (enExample) | ||
| WO2008043052A3 (en) | Human antibodies neutralizing human metapneumovirus | |
| AR088372A1 (es) | Solucion para administracion oral | |
| DE602007011384D1 (de) | Verfahren zur herstellung lipophiler pharmazeutisch akzeptabler salze aus pemetrexed-disäure | |
| RU2014108819A (ru) | Новые композиции и их применение | |
| JP2014050390A5 (enExample) | ||
| JP2016521746A5 (enExample) | ||
| IN2015DN02104A (enExample) | ||
| PH12014502423A1 (en) | Treatment of poultry, pigs or fish for reducing the feed conversion ratio or increasing their bodyweight gain |